Inventor
Kozak Jennifer
US17 patents
⚠️ This page may combine multiple inventors who share the name “Kozak Jennifer”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE BIOPHARMA R&D IP LLC
16 patentsUS10028960B2Jul 24, 2018
Pyrimidine compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC18 citations93
US9725470B2Aug 8, 2017
Substituted naphthyridines as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC27 citations93
US10308646B2Jun 4, 2019
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC11 citations92
US11420965B2Aug 23, 2022
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10774080B2Sep 15, 2020
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC5 citations84
US10562894B2Feb 18, 2020
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC7 citations84
US11780852B2Oct 10, 2023
Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
THERAVANCE BIOPHARMA R&D IP LLC3 citations83
US10947254B2Mar 16, 2021
Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
THERAVANCE BIOPHARMA R&D IP LLC3 citations83
US11110095B2Sep 7, 2021
Pyrimidine compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC3 citations72
US10952996B2Mar 23, 2021
ALK5 inhibitors
THERAVANCE BIOPHARMA R&D IP LLC2 citations71
US12358931B2Jul 15, 2025
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US12172994B2Dec 24, 2024
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11814377B2Nov 14, 2023
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11730720B2Aug 22, 2023
ALK5 inhibitors
THERAVANCE BIOPHARMA R&D IP LLC0 citations60
US11590116B2Feb 28, 2023
Substituted pyridines and methods of use
THERAVANCE BIOPHARMA R&D IP LLC1 citations60
US11673879B2Jun 13, 2023
Substituted pyrimidines and methods of use
THERAVANCE BIOPHARMA R&D IP LLC0 citations50